Certain unapproved therapeutic goods can now be supplied immediately to patients without requiring approval by the Therapeutic Goods Administration (TGA), under the new Special Access Scheme (SAS) Category C pathway. Now practitioners will be able to provide treatments that are deemed to have an established history of use to their patients [...]
HL Pharma are now using specialised thermal packaging for some of our cold chain deliveries. This technology is a sustainable option that lessens our carbon footprint and reduces waste as well as ensuring that our products are delivered to customers safely and protecting our temperature-sensitive products. At the moment we [...]
Currently there is a shortage in Australia of Antabuse (Disulfiram) Tablets Please contact us if you require further information.
Recently Voltaren (Diclofenac) Ophtha Single Use Eye Drops were discontinued in Australia. This product is still licensed and marketed in a number of European Countries and can be supplied under The Special Access Scheme, Please contact HL Pharma for more information. Voltaren (Diclofenac) Ophtha Single Use Eye Drops is useful [...]